Company profile: Evalve
1.1 - Company Overview
Company description
- Provider of devices enabling repair of cardiac valves, including a non-surgical mitral valve repair system comprising a steerable guide catheter, a clip delivery system, and an implant device used by interventional cardiologists to reduce mitral regurgitation; engaged in the design, development, manufacture, and marketing of these devices.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Evalve
CH Biomedical
HQ: United States
Website
- Description: Provider of ventricular assist device (VAD) technology utilizing an innovative magnetic levitation pump design, including the CH-VAD®, an implantable left ventricular assist system using full magnetic levitation to support heart function in patients with end-stage heart failure.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full CH Biomedical company profile →
Micell Technologies
HQ: United States
Website
- Description: Provider of biomedical device solutions focused on developing interventional cardiology systems for vascular drug delivery.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Micell Technologies company profile →
Eko
HQ: United States
Website
- Description: Provider of digital stethoscopes and an AI detection platform for heart and lung diseases, including CORE 500 with on-device ECG and heart rate display and Eko AI arrhythmia detection, 3M Littmann CORE, and the CORE Attachment with 40X amplification and noise cancellation, plus the Eko App to visualize, record, and share data; offers bulk group orders.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Eko company profile →
Fluidx Medical Technology
HQ: United States
Website
- Description: Provider of embolic devices and platforms for targeted vessel occlusion, designed for ease of use and delivery control, including GPX liquid embolic for deep occlusion in oncology and other uses; ULTRA peripheral embolic products with varied occlusion levels for hemorrhage; IMPASS neurovascular embolic for deep, distal penetration and middle meningeal artery embolization; and GPX-Clear with non-artifact radiopacity that dissipates for unobstructed visibility.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Fluidx Medical Technology company profile →
Artegraft
HQ: United States
Website
- Description: Provider of biologic vascular grafts derived from bovine carotid arteries, processed and sold for implantation primarily in hemodialysis patients, offering surgeons a biological alternative to synthetic grafts.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Artegraft company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Evalve
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Evalve
2.2 - Growth funds investing in similar companies to Evalve
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Evalve
4.2 - Public trading comparable groups for Evalve
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →